Tate & Lyle PLC ORD 29 1/6P/ GB00BP92CJ43 /
13/05/2024 14:45:37 | Chg. +6.5000 | Volume | Bid14:45:56 | Ask14:45:44 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
681.0000GBX | +0.96% | 239,122 Turnover(GBP): 1.6 mill. |
680.5000Bid Size: 1,106 | 682.0000Ask Size: 3,256 | 2.74 bill.GBP | - | - |
GlobeNewswire
14:50
Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
14:50
Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5...
GlobeNewswire
14:48
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Squarespace, I...
GlobeNewswire
14:36
DEADLINE TOMORROW: Berger Montague Advises Innoviz Technologies Ltd. (NASDAQ: INVZ) Investors to Inq...
GlobeNewswire
14:35
DeFi Technologies Inc. Featured in Syndicated Broadcast Covering Subsidiary’s AUM of C$748M, a 47.2%...
GlobeNewswire
14:33
Stanley Martin Holdings Acquires Prestige Corporate Development and Prestige Site Works
GlobeNewswire
14:30
Backblaze to Present at the 19th Annual Needham Technology, Media, & Consumer Conference
GlobeNewswire
14:30
Madison Realty Capital and Unity Capital Originate $100 Million Construction Loan for Mixed-Use Mult...
GlobeNewswire
14:30
Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Confere...
GlobeNewswire
14:30
Bitdeer Reports Unaudited Financial Results for the First Quarter of 2024 and Operational Update